The Growing Relevance of Traditional Medicine

India’s ₹43.4 Billion AYUSH Industry: Promise, Pitfalls, and Global Aspirations

By 2025, the global traditional medicine market is projected to surge to $583 billion, marking a seismic shift in healthcare paradigms toward prevention and holistic well-being. For India, whose AYUSH sector is valued at ₹43.4 billion and growing nearly eight-fold in a decade, this signals both opportunity and obligation. Yet, behind these dazzling numbers lies a complex tapestry of institutional triumphs, global positioning, and glaring inefficiencies.

A Ministry Born of Ambition

The establishment of the Ministry of AYUSH in 2014 formalized India's age-old commitment to Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homoeopathy systems. Legally fortified through schemes like the National AYUSH Mission (NAM)—implemented via State and UT governments—the department aims to integrate traditional medicine into mainstream healthcare. Key initiatives include the creation of AYUSH Health & Wellness Centres under the Ayushman Bharat framework and the promotion of AYUSH lifestyles in rural areas through AYUSH Grams.

Spending has grown exponentially. Research institutions like the Central Council for Research in Ayurvedic Sciences and the National Institute of Ayurveda are tasked with clinical trials, drug standardization, and the development of hybrid care models. Furthermore, export-focused bodies such as the Ayush Export Promotion Council (AYUSHEXCIL) aim to expand India’s footprint in global markets. Few countries offer such organizational depth to systematize traditional medicine.

Rhetoric vs Reality: A Closer Look

Despite its veneer of success, gaps persist in India’s AYUSH ecosystem. Consider this: India exports AYUSH products worth ₹1.54 billion annually across 150 countries. Yet, China’s traditional medicine sector dwarfs that figure with a valuation of $122.4 billion. India’s reliance on small-scale enterprises—the AYUSH sector comprises over 92,000 MSMEs—limits market consolidation, pharmaceutical-grade production, and global competitiveness.

The issue extends beyond economics. The Ministry of AYUSH lauds "scientific validation" in traditional medicine. But peer-reviewed transparency remains patchy. Regulatory standards for herbal drugs, particularly under Schedule T of the Drugs and Cosmetics Act, lack uniform implementation across states. Moreover, questions about efficacy, when tested against rigorous double-blind clinical trials, dog the sector. Such skepticism isn't unfounded, especially considering WHO's stringent benchmarks for traditional medicine practices.

Another blind spot lies in public health integration. While AYUSH Health & Wellness Centres under Ayushman Bharat aim to marry traditional medicine with primary healthcare, coordination between AYUSH practitioners and allopathic doctors has been inconsistent. The threat of parallel systems rather than collaborative frameworks—less a merger, more an uneasy coexistence—remains pronounced.

Lessons from China

China offers an instructive counterpoint. While India has 39 AYUSH information cells globally, China has institutionalized research collaborations across continents. For instance, the Chinese government funds international laboratories in Africa and Southeast Asia to study herbal protocols for malaria and respiratory diseases. Unlike India, which grapples with fragmented manufacturing, China boasts a centralized infrastructure for traditional medicine exports. Notably, the seamless integration of Traditional Chinese Medicine (TCM) into national health insurance schemes fosters broader accessibility and credibility among the population.

For India, the absence of universal insurance coverage for AYUSH systems is telling. Despite provisions under NAM to promote AYUSH in rural and urban areas, state-level buy-in varies widely. The gap between promising central schemes and uneven state implementation mirrors broader Centre-state disconnects in Indian policymaking.

Beneath the Global Gloss

The Ministry’s international initiatives strike an ambitious tone: 25 bilateral agreements, 52 institutional partnerships, and recognition of Ayurveda as a traditional medicine system in over 30 countries. The establishment of the WHO Global Traditional Medicine Centre (GTMC) in Jamnagar has rightly been hailed as a diplomatic coup. Even the introduction of a bespoke Ayush Visa for foreign nationals emphasizes India’s positioning as a wellness tourism hub.

But the euphoria risks obscuring critical questions. How sustainable are these achievements given the absence of mechanisms—like China’s central research hubs—to ensure global adoption of these practices? Are bilateral agreements mere paper or tools of substantive trade facilitation? And critically, can AYUSH scale ethically without succumbing to the pitfalls of unregulated commercialization?

Pathways for Success

A robust AYUSH strategy requires structural recalibration. First, the Ministry must make transparency non-negotiable; clinical trial data, pharmacological studies, and herbal drug standards need public access. Second, insurance coverage across states for AYUSH therapies would enhance domestic adoption. The funding disparity between AYUSH and allopathy-based public health initiatives must narrow.

Finally, state governments need greater agency in AYUSH schemes. Decentralized herb cultivation initiatives tied directly to local economies—akin to NAM’s AYUSH Grams—can strengthen supply chains while benefiting rural livelihoods. Success metrics should go beyond exports; tracking health outcomes associated with AYUSH therapies in primary care settings will build public trust.

UPSC Integration

For Prelims:

• Question 1: Which legislation provides regulatory standards for AYUSH-based herbal drugs?
  • (a) Clinical Establishments Act
  • (b) Drugs and Cosmetics Act
  • (c) National AYUSH Mission
  • (d) Medical Termination of Pregnancy Act

  Answer: (b) Drugs and Cosmetics Act

• Question 2: What is the primary aim of AYUSH Grams under NAM?
  • (a) Promotion of herbal exports
  • (b) AYUSH lifestyle adoption in rural areas
  • (c) International collaborations for Ayurveda research
  • (d) Training AYUSH doctors for urban clinics

  Answer: (b) AYUSH lifestyle adoption in rural areas

For Mains:

Critically evaluate whether India’s AYUSH strategy sufficiently addresses global market competitiveness and domestic healthcare integration. Highlight structural limitations and compare with relevant international models.

Practice Questions for UPSC

Prelims Practice Questions

Frequently Asked Questions